Combined Use of Cabozantinib and Nivolumab in Clinical Practice

Combined Use of Cabozantinib and Nivolumab in Clinical Practice

Introduction. The present article discusses renal cancer, one of the common malignant diseases. Historical and modern therapies are considered, including tyrosine kinase inhibitors and immune checkpoint inhibitors. The results of clinical studies evaluating the efficacy of combined drug therapy are...

Full description

Saved in:
Bibliographic Details
Main Authors: V. E. Askarov, A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, N. I. Sultanbaeva, E. V. Popova, I. A. Menshikova
Format: Article
Language:English
Published: Bashkir State Medical University 2024-04-01
Series:Креативная хирургия и онкология
Subjects:
renal cell cancer
cabozantinib
nivolumab
chemotherapy
immunotherapy
tyrosine kinase inhibitors
vascular endothelial growth factor
Online Access:https://www.surgonco.ru/jour/article/view/921
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.surgonco.ru/jour/article/view/921

Similar Items